The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 6410 -6417
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0802512

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, A.
Right arrow Articles by Gallin, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, A.
Right arrow Articles by Gallin, J. I.

Impaired Priming and Activation of the Neutrophil NADPH Oxidase in Patients with IRAK4 or NEMO Deficiency1

Anjali Singh*, Kol A. Zarember*, Douglas B. Kuhns{dagger} and John I. Gallin2,*

* Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, and {dagger} Clinical Services Program, SAIC-Frederick, National Cancer Institute, Frederick, MD 21702

The NADPH oxidase (NOX), an oligomeric enzyme, plays a key role in polymorphonuclear neutrophil (PMN)-mediated host defense by producing cytotoxic superoxide anion (O2Formula ). Whereas in vitro and biochemical studies have examined the assembly and activation of this important host immune defense system, few studies have examined the function of NOX in human patients with primary immunodeficiency other than chronic granulomatous disease. We studied the activation of NOX in PMN from patients with two distinct immunodeficiencies, IL-1R-associated kinase (IRAK)4 deficiency and NF-{kappa}B essential modulator (NEMO or I{kappa}B kinase {gamma}) deficiency. We observed impaired O2Formula generation by LPS-treated and fMLP-activated IRAK4-deficient PMN that correlated with decreased phosphorylation of p47phox and subnormal translocation of p47phox, p67phox, Rac2, and gp91phox/Nox2 to the membranes indicating that TLR4 signaling to the NOX activation pathway requires IRAK4. NEMO-deficient PMN generated significantly less O2Formula in response to LPS-primed fMLP and translocated less p67phox than normal PMN, although p47phox and Rac2 translocation were normal. Generally, responses of NEMO-deficient cells were intermediate between IRAK4-deficient cells and normal cells. Decreased LPS- and fMLP-induced phosphorylation of p38 MAPK in both IRAK4- and NEMO-deficient PMN implicates additional signal transduction pathways in regulating PMN activation by LPS and fMLP. Decreased activation of NOX may contribute to the increased risk of infection seen in patients with IRAK4 and NEMO deficiency.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and the National Institutes of Health Clinical Center.

2 Address correspondence and reprint requests to Dr. John I. Gallin, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, Room 6-2551, MSC 1504, Bethesda, MD 20892-1504. E-mail address: jgallin{at}cc.nih.gov

3 Abbreviations used in this paper: PMN, polymorphonuclear neutrophil; IRAK, IL-1R-associated kinase; NEMO, NF-{kappa}B essential modulator; NOX, NADPH oxidase; MF, membrane fraction.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. R. Errante, C. Prando, J. Bustamante, W. C. Aragao Filho, P. V. S. Pereira, J. Rehder, J. L. Casanova, P. Newburger, and A. C. Neto
Comment on "Impaired Priming and Activation of the Neutrophil NADPH Oxidase in Patients with IRAK4 or NEMO Deficiency"
J. Immunol., September 15, 2009; 183(6): 3559 - 3559.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.